Both cfDNA and syndecan-1 levels are reported for mortality predictions in septic subjects and are associated with adverse clinical outcomes (e.g., development of multiple organ failure, ARDS) [14,34]. This evidence concerns the gene SDC1 and Multiple Organ Failure.